Replimune
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.About REPL
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer.
CEOSushil Patel
CEOSushil Patel
Employees479
Employees479
HeadquartersWoburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded2015
Founded2015
Employees479
Employees479
REPL Key Statistics
Market cap821.30M
Market cap821.30M
Price-Earnings ratio-2.92
Price-Earnings ratio-2.92
Dividend yield—
Dividend yield—
Average volume1.85M
Average volume1.85M
High today$10.54
High today$10.54
Low today$10.27
Low today$10.27
Open price$10.34
Open price$10.34
Volume423.95K
Volume423.95K
52 Week high$14.80
52 Week high$14.80
52 Week low$2.68
52 Week low$2.68
Stock Snapshot
As of today, Replimune(REPL) shares are valued at $10.47. The company's market cap stands at 821.3M, with a P/E ratio of -2.92.
During the trading session on 2025-12-05, Replimune(REPL) shares reached a daily high of $10.54 and a low of $10.27. At a current price of $10.47, the stock is +1.9% higher than the low and still -0.7% under the high.
Trading volume for Replimune(REPL) stock has reached 423.95K, versus its average volume of 1.85M.
The stock's 52-week range extends from a low of $2.68 to a high of $14.80.
The stock's 52-week range extends from a low of $2.68 to a high of $14.80.
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
25%
Sell
0%
People also own
Based on the portfolios of people who own REPL. This list is generated using Robinhood data, and it’s not a recommendation.